Previous
Poster Home
Next
Real-world clinical benefit among patients with lower-risk myelodysplastic syndromes treated with luspatercept
07:30am - 03:35pm EDT - April 5, 2024
Information
Resources
Play Recording
Abstract: JNCCN23-0620
https://jnccn.org/view/journal...
Author(s):
Kashyap Patel, MD
, Minnesota Oncology
Derek Tang, PhD, MS, BSPharm
, Health Outcomes Research Leader, Bristol-Myers Squibb
Tags:
Outcomes and Health Services Research
Display Label
Action
NCCN 2024 Patel poster_RW Outcomes with 1L Lusp_HR.pdf
Download Handout